BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12351425)

  • 1. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.
    Cline GW; Johnson K; Regittnig W; Perret P; Tozzo E; Xiao L; Damico C; Shulman GI
    Diabetes; 2002 Oct; 51(10):2903-10. PubMed ID: 12351425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
    Henriksen EJ; Teachey MK
    Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
    Ring DB; Johnson KW; Henriksen EJ; Nuss JM; Goff D; Kinnick TR; Ma ST; Reeder JW; Samuels I; Slabiak T; Wagman AS; Hammond ME; Harrison SD
    Diabetes; 2003 Mar; 52(3):588-95. PubMed ID: 12606497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
    Dokken BB; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.
    Ruzzin J; Wagman AS; Jensen J
    Diabetologia; 2005 Oct; 48(10):2119-30. PubMed ID: 16078016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin improves response to glucose tolerance test in control and diabetic rats.
    López-Soldado I; Niisuke K; Veiga C; Adrover A; Manzano A; Martínez-Redondo V; Camps M; Bartrons R; Zorzano A; Gumà A
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E440-51. PubMed ID: 26714846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.
    Liu Z; Wu Y; Nicklas EW; Jahn LA; Price WJ; Barrett EJ
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E523-8. PubMed ID: 14656717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
    Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
    Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
    Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3.
    Dokken BB; Saengsirisuwan V; Kim JS; Teachey MK; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E615-21. PubMed ID: 18089761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance.
    Kim KM; Lee KS; Lee GY; Jin H; Durrance ES; Park HS; Choi SH; Park KS; Kim YB; Jang HC; Lim S
    Mol Cell Endocrinol; 2015 Jul; 409():1-10. PubMed ID: 25802191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
    Rossetti L; Lauglin MR
    J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.
    Lailerd N; Saengsirisuwan V; Sloniger JA; Toskulkao C; Henriksen EJ
    Metabolism; 2004 Jan; 53(1):101-7. PubMed ID: 14681850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
    Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
    J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
    Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
    Henriksen EJ; Dokken BB
    Curr Drug Targets; 2006 Nov; 7(11):1435-41. PubMed ID: 17100583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.